US FDA warns 30 telehealth firms over misleading ads for compounded weight‑loss drugs

The U.S. Food and Drug Administration has issued warning letters to 30 telehealth companies for making false or misleading ...
Cyclingnews

'Easier than getting a bag of sweets from the shops' - Weight loss drugs are everywhere, but are they a recipe for disaster or game changer for cyclists?

Weight loss drugs are more popular than ever, even in cycling, but do the health benefits some are seeing outweigh the risks ...
Seeking Alpha

Eli Lilly boosts weight loss pill inventory ahead of FDA decision

Eli Lilly (LLY) has built up its inventory for its experimental weight loss pill, orforglipron, as the Indiana-based pharma giant awaits a potential FDA approval for the oral GLP-1 drug over the ...
Benzinga.com

Eli Lilly Builds $1.5 Billion Inventory Of Experimental Weight-Loss Pill As FDA Decision Looms

Eli Lilly and Company (NYSE: LLY) has stockpiled $1.5 billion worth of inventory of its experimental oral weight-loss drug, orforglipron, according to a regulatory filing on Thursday. This significant ...
AOL

New weight-loss pill: 6 things you should know

For decades, researchers have been looking for an effective weight-loss pill. But the recent success of glucagon-like peptide-1 (GLP-1) weight-loss injections has sparked new hope — especially for ...
Wall Street Journal

Novo Nordisk Stock Soars After Hims & Hers Scraps Copycat Weight-Loss Pill

Novo Nordisk stock surged after Hims & Hers scrapped plans to sell a copycat version of the drugmaker’s weight-loss pill following pressure from U.S. regulators. Shares in Novo Nordisk jumped nearly 7 ...
Boston Herald

Ticker: Hims & Hers drops plans for knockoff weight loss pill; Washington Post editor steps down

Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy — two days after it announced the new drug and one day after the Food and Drug Administration ...
CNBC

Hims & Hers pulls copycat weight-loss pill after threats of legal action

Hims & Hers on Saturday said it would stop offering its copycat Wegovy weight-loss pill. The decision comes after Novo Nordisk, maker of Wegovy, and the U.S. Food and Drug Administration threatened ...
WTOP News

Hims & Hers drops plan for knockoff of Novo Nordisk’s new Wegovy weight loss pill

Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy on Saturday — two days after it announced the new drug and one day after the Food and Drug ...
The New York Times

Facing Regulatory Scrutiny, Hims & Hers Withdraws Knockoff Obesity Pill

Federal officials had warned that the new product from the online provider of weight loss drugs might be illegal. By Rebecca Robbins Hims & Hers, a major online provider of obesity medications, said ...
Investopedia

Hims & Hers Launches New Pill That Sends Shockwaves Across Weight-Loss Drugmakers' Stocks

Aaron McDade is a breaking news reporter for Investopedia. He is an experienced journalist who has covered everything from the latest in business and tech news to sports and international news like ...